{
  "input": {
    "mode": "init",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_omega_3_fatty_acids",
          "name": "Omega-3 fatty acids"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_statins",
          "name": "Statins"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_ezetimibe",
          "name": "Ezetimibe"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_lomitapide",
          "name": "Lomitapide"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_pcsk9_inhibitors",
          "name": "PCSK9 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_triglyceride_lowering_agents",
          "name": "Triglyceride-lowering agents"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_cetilistat",
          "name": "Cetilistat"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_orlistat",
          "name": "Orlistat"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_bempedoic_acid",
          "name": "Bempedoic acid"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_sofosbuvir",
          "name": "Sofosbuvir"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "budgets": {
      "round_limit": 3,
      "token_limit": 200000
    },
    "heuristic_priors": [
      {
        "when": "general biomedical reasoning",
        "then": "区分短期表型与长期结局；明确潜在风险链"
      }
    ],
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "plan": {
      "rounds": 1,
      "graph_expectations": [
        "补充 Drug→Target/Pathway→Disease 的连通性",
        "明确各候选药物的疗效与机制相关性"
      ],
      "scoring_weights": {
        "mechanism_fit": 0.3,
        "class_prior": 0.2,
        "pk_pd_feasibility": 0.2,
        "indication_plausibility": 0.2,
        "safety_risk": 0.1,
        "graph_bonus": 0.1,
        "conflict_penalty": 0.1
      },
      "stopping": {
        "max_rounds": 3,
        "delta_threshold": 0.03,
        "saturation_ratio": 0.65
      },
      "seed_policy": {
        "default": "conservative",
        "cooldown_rounds": 1,
        "max_regenerations": 1,
        "gate_thresholds": {
          "topk": 3,
          "min_disjointness": 2,
          "support_sum_max": 0.35,
          "conflict_over_support_ratio_min": 1.2
        },
        "required_prior_actions": [
          "add_mechanism_link",
          "add_disjoint_path",
          "merge_claims",
          "add_outcome_nodes",
          "stress_test_safety"
        ]
      }
    }
  }
}